ArticleJournal of Cancer2022

Serum exosomal miR-34a as a potential biomarker for the diagnosis and prognostic of hepatocellular carcinoma.

Shuying Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.